GlassScriptPhysician profile
Brandon Garske
NPI 1902688336
$782.66
in general payments reported to CMS, 2019-2025
9 companies · $295 in 2025
The $295 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $488 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $699 · Education: $83.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $698.67 |
| Education | $83.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $208.42 | 2024-2025 | Opdivo |
| Syndax Pharmaceuticals, INC. | $127.00 | 2025 | Revuforj |
| Abbvie INC. | $123.42 | 2024 | |
| Pfizer INC. | $115.26 | 2024 | |
| Incyte Corporation | $83.99 | 2024 | |
| Janssen Biotech, INC. | $57.14 | 2024-2025 | Rybrevant, Tecvayli |
| Tempus Ai, INC | $26.05 | 2024 | Xt Cdx |
| Exelixis INC. | $22.21 | 2025 | Cabometyx |
| Genentech USA, INC. | $19.17 | 2025 | Tecentriq Hybreza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Garske listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.